Update shared on 14 Nov 2025
Fair value Increased 4.12%Analysts have raised their price target for Bunge Global from $99.67 to $103.78. This reflects recent adjustments in revenue growth projections and updated discount rate assumptions.
What's in the News
- From July 1, 2025 to November 5, 2025, Bunge Global repurchased 6,672,777 shares, representing 4.96% of outstanding shares for $544.5 million. The company has now completed the buyback of 26,340,516 shares, equal to 18.52% for $2,444.54 million under its program announced on October 27, 2021 (Key Developments).
- Bunge Global SA (NYSE:BG) has been dropped from the FTSE All-World Index (USD) (Key Developments).
Valuation Changes
- The Fair Value Estimate has increased from $99.67 to $103.78, reflecting a moderate rise in projected valuation.
- The Discount Rate has risen slightly from 6.78% to 6.97%, indicating updated risk and return expectations.
- The Revenue Growth projection has decreased significantly from 33.53% to 25.09%.
- The Net Profit Margin estimate has edged down from 1.87% to 1.82%.
- The Future P/E Ratio is higher at 14.02x, compared to the previous estimate of 13.15x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.